Restrictions on obesity drug coverage force patients to pivot
Quick Insights
The Bottom Line
Millions of people lost insurance coverage for popular obesity drugs Zepbound and Wegovy in the last year.
How This Affects You
If you rely on Zepbound or Wegovy, your insurance coverage may have been dropped, forcing you to find alternative treatments or pay higher out-of-pocket costs.
AI Summary
An analysis by GoodRx, a drug discount website, reveals that twelve million people lost coverage for Zepbound over the last year. An additional twelve million people also lost coverage for Wegovy during the same period. These restrictions on obesity drug coverage are forcing patients to pivot to other options. The report highlights a significant reduction in insurance access for these popular medications.
Following this story?
Get notified when new coverage appears
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
PoliticsFACT FOCUS: Trump says drug trafficking by sea is down 98.2%. The numbers don't show that - AP News
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxPN0hCS3FkWU9qY3ZET3l2WjVnTTZhYXFxWnFWZ2dGMU0yYno3akxuRG9BMmdIdVltMVAyNXRrNVpkR2RhcFo4OVp6MzY2clFYV0JLRlpMSUNDN3lzMlgwWVdmR2VFemd3NXJSX3dsWU9Eam9BMHVFWjBOeF9EV3JkVE1aRUJzSFFtME1JZHlRSkVKYzJpZG5lY19MQ25pa01lbDBXTnpB?oc=5" target="_blank">FACT FOCUS: Trump says drug trafficking by sea is down 98.2%. The numbers don't show that</a> <font color="#6f6f6f">AP News</font>
HealthOne in three Americans forced to make financial sacrifices for health coverage
At a moment when there's a lot of political attention around questions of affordability, rising health care costs are a growing concern for many Americans. That's especially true for those who are worried about being able to afford insurance premiums after an expansion of subsidies for the Affordable Care Act expired. But they're not the only ones struggling with this. Stephanie Sy reports.
HealthBreakthrough £90,000 Alzheimer's drugs unlikely to benefit patients, report suggests
A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.
PoliticsForced out of the military — and into the redistricting wars - Politico
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNb0hKNHFIRk9uV1ZBaHY2YjVGaXA2UU1DemRBMVdtcmRZWUZhM2ZTMzZvUFhCMDc4N21YUDJ3bmVYR1lDaWZwaC1aX09YQmdqcnM4M3c4bmswbnpXeTNfMGN1U04xTmFabEI5bnpXZFVqQ3NicGhmY0Via0dVanZSNlJIOVJJbEFVYURMYzBfTmx0cnYtbVVxLWs4YU5hT2swNjZlRWZMUzl2Q1o1T0trRTFISkItU3UxYnhZanl4M3F5Zw?oc=5" target="_blank">Forced out of the military — and into the redistricting wars</a> <font color="#6f6f6f">Politico</font><strong><a href="https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZjbmt0TXpZd1NoRUtEd2lzcThqMUVCRzctUjdFd29lZ0F5Z0FQAQ?hl=en-US&gl=US&ceid=US:en&oc=5" target="_blank">View Full Coverage on Google News</a></strong>
Government TransparencyHomeland Security’s New Task Force Website Sanitizes Trump’s Deportation Agenda
The Department of Homeland Security just rolled out a new website for its city-occupying task forces that looks, more than anything, like a vibe-coded pitch deck. Launched on Friday, HSTF.gov was first announced on the FBI’s X account. We don’t negotiate. We dismantle. The site’s slogan is displayed in the same sans-serif font stylings as […]
HealthReport: Merck’s blockbuster cancer drug topped $200,000 a year under Trump
Despite the president’s plan to lower prescription medicine costs, the price of many of the most expensive drugs — including several immunotherapy treatments — have continued to rise.

Louisiana gunman had sought mental health treatment, relatives say
The man who killed eight children and wounded two women in Louisiana had sought mental health care from Veterans Affairs.
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
Report: Merck’s blockbuster cancer drug topped $200,000 a year under Trump

One in three Americans forced to make financial sacrifices for health coverage

US Live Nation and Ticketmaster verdict triggers calls for Australian investigation into ticketing rules

Welcome to the Second Gilded Age

Steve Bannon sides with Anthropic in fight with Pentagon: ‘It’s almost too dangerous’


